William Blair Investment Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History
William Blair Investment Management, LLC
- $38.3 Billion
- Q4 2024
A detailed history of William Blair Investment Management, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, William Blair Investment Management, LLC holds 371,771 shares of MDGL stock, worth $115 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
371,771Holding current value
$115 Million% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$683 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$632 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$628 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$617 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$611 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.29B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...